电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

Interferon Regulatory Factor 4 (IRF4) Peptide

IRF4 适用: 人 宿主: 合成 BP, WB
产品编号 ABIN978602
发货至: 中国

Quick Overview for Interferon Regulatory Factor 4 (IRF4) Peptide (ABIN978602)

抗原

IRF4 (Interferon Regulatory Factor 4 (IRF4))

宿主

资源

  • 5
合成

应用范围

Blocking Peptide (BP), Western Blotting (WB)
  • 产品特性

    This is a synthetic peptide designed for use in combination with anti-IRF4 antibody (Catalog #: ARP32669_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    纯化方法

    Purified
  • 应用备注

    Each Investigator should determine their own optimal working dilution for specific applications.

    限制

    仅限研究用
  • 状态

    Lyophilized

    溶解方式

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    浓度

    1 mg/mL

    缓冲液

    Final peptide concentration is 1 mg/mL in PBS.

    注意事项

    Avoid repeated freeze-thaw cycles.

    储存条件

    -20 °C

    储存方法

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • 抗原

    IRF4 (Interferon Regulatory Factor 4 (IRF4))

    背景

    IFN regulatory factor (IRF)-4 is a lymphoid/myeloid-restricted member of the IRF transcription factor family that plays an essential role in the homeostasis and function of mature lymphocytes. IRF-4 expression is tightly regulated in resting primary T cells and is transiently induced at the mRNA and protein levels after activation by Ag-mimetic stimuli such as TCR cross-linking or treatment with phorbol ester and calcium ionophore (PMA/ionomycin).

    Alias Symbols: MUM1, LSIRF, NF-EM5

    Protein Interaction Partner: BCL6,FKBP4,MYD88,NFATC2,PRDM1,SPI1,SPIB,STAT6,TRAF2,BCL6,FKBP4,NFATC2,Prdm1,SPI1,STAT6,TRAF2

    Protein Size: 451

    分子量

    52 kDa

    基因ID

    3662

    NCBI登录号

    NM_002460, NP_002451

    UniProt

    Q15306
You are here:
Chat with us!